Part of the reason for this is that Medicare reimbursement rates for older adult mental health and substance use is inadequate for engaging providers to enroll.
Bob Casey
The Public Record
Robert P. Casey is a United States Senator from Pennsylvania, having served since January 4, 2007. A member of the Democratic Party, he has focused on a range of issues including healthcare, education, and economic development. Throughout his tenure, Casey has been an advocate for policies aimed at improving access to healthcare and supporting working families. He has also been involved in efforts to address climate change and promote job growth in Pennsylvania.
Mental health care is a critical component of our overall health care system.
I represent a state that has 67 counties, but we have 48 counties that are considered rural.
One of the big challenges, of course, is these rural hospitals and rural health centers don't have the resources that some of the big cities do.
I don`t think we should be banning abortion and the only legislation now that is in front of us is this bill which would prevent a ban like that from going forward.
We now know that because of that decision, that older adults face a higher burden of proof when making a discrimination claim.
I think addressing pregnancy discrimination in the workplace is of central importance and overlaps with other issues that we have discussed, including the gender wage gap.
Fortunately, now we have a bill in the Senate, imagine this it is bipartisan, that we are trying to pass.
Fortunately, that number is down from where it was a number of years ago, but it is still too high.
We know now that in the Nation we have got just about 1,000 employers across the country that are permitted to pay their employees with disabilities a wage below the minimum wage.
It undermined, weakened the age discrimination in employment or the so-called ADEA, and sent what I think is a damaging and negative message.
Well, I hope that, were you to be confirmed, that would be a priority for you. This is a matter that has been around way too long. We candidly, the U.S. Congress hasn't done enough.
I want to start by thanking Ms. Kotagal for her willingness to put herself forward for this nomination.
Senator Grassley and I introduced the Protecting Older Workers Against Discrimination Act.
I subsequently introduced S. 4071, the Helping Experts Accelerate Rare Treatments Act of 2022 with Senator Tim Scott.
I am concerned that progress on these technologies could be slowed by insufficient face-to-face communication--the intention for these meetings--and an overreliance on WROs.
I have been particularly excited to hear about tremendous progress in the area of cell and gene therapy and the promise they hold in curing devastating diseases and transforming the lives of patients.
Antimicrobial resistance is a public health crisis, and no single solution is going to fix the problem.
We need creative ideas that can realign current market incentives to encourage drug developers to stay in this business.
Key among these challenges is reaching agreement with regulators about determining the appropriate efficacy endpoints to support approval of innovative medicines for rare diseases.
The financial realities of developing these new agents remain very challenging.
I am proud to lead a bipartisan bill, the STURDY Act, alongside Senators Klobuchar, Blumenthal and Cotton.
Mandatory stability standards would make our homes safer overall, but especially for children.





